Synthesis of novel 1,4- dihydropyridine derivatives bearing biphenyl-2'-tetrazole substitution as potential dual angiotensin II receptors and calcium channel blockers

Advanced Pharmaceutical Bulletin

Volumn 1, Issue 1, 2011, Pages 1-9

  Mojarrad, Javid Shahbazi ^a   Zamani, Zahra ^a   Nazemiyeh, Hossein ^a,b   Ghasemi, Saeed ^a   Asgari, Davoud ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,4 dihydropyridine; Angiotensin ii blocker; Biphenyl 2' tetrazole; Calcium channel blocker

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 2 N PROPYL 1 [[2' (1H TETRAZOLE 5 YL)BIPHENYL 4 YL]METHYL]IMIDAZOLE 4 CARBOXALDEHYDE; 2 N PROPYL 1 [[2' [(TRIPHENYLMETHYL)TETRAZOLE 5 YL]BIPHENYL 4 YL]METHYL]IMIDAZOLE 4(5) CARBOXALDEHYDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIMETHYL 1,4 DIHYDRO 2,6 DIMETHYL 4 [2 N BUTYL 1 [[2' (1H TETRAZOLE 5 YL)BIPHENYL 4 YL]METHYL]IMIDAZOLE 4 YL]3,5 PYRIDINEDICARBOXYLATE; DIMETHYL 1,4 DIHYDRO 2,6 DIMETHYL 4 [2 N BUTYL 1 [[2' (1H TETRAZOLE 5 YL)BIPHENYL 4 YL]METHYL]IMIDAZOLE 5 YL]3,5 PYRIDINEDICARBOXYLATE; LOSARTAN; NIFEDIPINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HANTZSCH CONDENSATION REACTION; HEART PROTECTION; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; RENAL PROTECTION; STRUCTURE ANALYSIS;

EID: 84875912424     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2011.001     Document Type: Article

References (21)

1. Williams DA, Lemke TL. Foye's Principles of Medical Chemistry. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. 533-561.
2. Shafiee A, Hadizadeh F, Foroumadi A. Syntheses of substituted pyrrolo [3,2- d] imidazoles. Ind J Chem 1997; 36: 813.
3. Foroumadi A, Analuie N, Rezvanipour M, Sepehri G, Najafipour H, Sepehri H. Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthio imidazole substituent. IL Farmaco 2002; 57:195.
4. Hosseini M, Miri R, Amini M, Mirkhani H, Hemmateenejad B, Ghodsi S, Alipour E, Shafiee A. Synthesis, QSAR and calcium channel antagonist activity of new 1,4 dihydropyridine derivatives containing1-methyl-4,5-dichloroimidazolyl substituents. Arch Pharm (Weinheim) 2007; 340: 549-56.
5. Shafiee A, Rastkary N, Jorjani M. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents. Arzneimittelforschung 2002; 52: 537-42.
6. Shafiee A, Rastkary N, Jorjani M, Shafaghi B. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position. Arch Pharm (Weinheim) 2002; 335: 69-76.
7. Shahbazi-Mojarrad J, Miri R, Knaus EE. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[410] hept-3-ene-4-carboxylates with calcium channel antagonist activity. Bioorg Med Chem 2004; 12: 3215-20.
8. Shahbazi-Mojarrad J, Vo D, Velazquez C, Knaus EE. Design and synthesis of alkyl 7,7-dihalo-3-methyl-5-(nitrophenyl)-2-azabicyclo[410]hept-3-ene-4-carbox ylates with calcium channel antagonist activity. Bioorg Med Chem 2005; 13: 4085.
9. Arun KHS, Kaul CL, Ramarao P. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats. Cardiovascular Research 2005; 65: 374-386
10. Hasebea N, Kikuchi K. Controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: NICE Combi (Nifedipine and Candesartan Combination) Study. Journal of Hypertension 2005; 23: 445.
11. Okuda NT, Hayashi Mori T, Inamoto S, et al. Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. Hypertens Res 2005; 28: 431-8.
12. Swales P, Williams B. Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT1-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension. J Renin Angiotensin Aldosterone Syst 2002; 3:79-89.
13. Shahbazi-Mojarrad J, Nazemiyeh H, Kaviani F. Synthesis and Regioselective Hydrolysis of Novel Dialkyl 4-Imidazolyl-1,4-Dihydropyridine-3,5-dicaroxlates as Potential Dual Acting Angiotensin II Inhibitors and Calcium Channel Blockers. J Iran Chem Soc 2010; 7: 171.
14. Hadizadeh F, Imenshahidi M, Esmaili P, Taghiabadi M. Synthesis and Effects of Novel Dihydropyridines as Dual Calcium Channel Blocker and Angiotensin Antagonist on Isolated Rat Aorta. Iranian Journal of Basic Medical Sciences 2010; 13: 195.
15. Sausins AE, Duburs G. Synthesis of 1,4-dihydropyridine in Chemistry of Heterocyclic Compounds, Springer New York,. 1992; 28(4): 363.
16. Weidenhagen R, Herrmann R. Eine neue synthese von imidazol- derivaten. Ber 1935; 68: 1953- 1961.
17. Carini DJ, Duncia JV, Aldrich PE, Chiu AT, Johnson AL, Pierce WA, et al. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl) imidazoles as potent, orally active antihypertensives. J Med Chem 1991; 34: 2525-47.
18. Shafiee A, ShahbaziMojarrad J, Jalili MA, Adhami HR, Hadizadeh F. Syntheses of substituted pyrrolo [2,3-d]imidazole-5-carboxylates and substituted pyrrolo[3,2-d]imidazole-5-carboxylates. J Heterocycl Chem 2002; 39: 367.
19. DaSilva JA, Barríab CS, Jullianb C, Navarreteb P, NúñezVergaraa L, Squellaa JA. Unexpected diastereotopic behaviour in the 1H NMR spectrum of 1,4-dihydropyridine derivatives triggered by chiral and prochiralcentres. J Braz Chem Soc 2005; 16: 112.
20. Núnnez-Vergara LJ, Navarrete-Encina PA, Salas S, Conde B, Carbajo j, Squella JA, Camargo C. Analyses by GC-MS and GC-MS-MS of the hantzsch synthesis products using hydroxy- and methoxy-aromatic aldehydes. J Pharm Biomed Anal 2007; 44: 236-42.
21. Lopez-Alarcon C, Squella JA, Núnnez-Vergara LJ, Baez H, Camargo C. Gas chromatography/mass spectrometric study of non-commercial C-4-substituted 1,4-dihydropyridines and their oxidized derivatives. Rapid Commun Mass Spectrom 2002; 16: 2229-38.